CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,898,837
- in 74 filings, $342.1M under 10b5-1 plans
Net −$342,898,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-30 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −480 | $594.74 | $285K | 22,333 |
| 2026-03-30 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −500 | $595.91 | $298K | 21,833 |
| 2026-03-30 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −204 | $596.74 | $122K | 21,629 |
| 2026-03-30 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −240 | $597.72 | $143K | 21,389 |
| 2026-03-30 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −200 | $598.83 | $120K | 21,189 |
| 2026-03-30 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −790 | $599.82 | $474K | 20,399 |
| 2026-03-30 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −212 | $601.43 | $128K | 20,187 |
| 2026-03-30 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −417 | $602.53 | $251K | 19,770 |
| 2026-03-30 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −103 | $603.69 | $62K | 19,667 |
| 2026-03-30 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −770 | $604.64 | $466K | 18,897 |
| 2026-03-30 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −21 | $606.53 | $13K | 18,876 |
| 2026-03-30 | EDGEMOND JAMES CFO AND TREASURER | Option exercise · Stock Option 10b5-1 | −10,000 | 132,500 | ||
| 2026-03-30 | CAUSEY CHRISTOPHER Director | Option exercise 10b5-1 | +1,300 | $119.76 | $156K | 5,490 |
| 2026-03-30 | CAUSEY CHRISTOPHER Director | Sale 10b5-1 | −1,300 | $604.64 | $786K | 4,190 |
| 2026-03-30 | CAUSEY CHRISTOPHER Director | Option exercise · Stock Option 10b5-1 | −1,300 | 5,000 | ||
| 2026-03-30 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $146.03 | $1.4M | 50,013 |
| 2026-03-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −80 | $581.74 | $47K | 49,933 |
| 2026-03-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −160 | $583.40 | $93K | 49,773 |
| 2026-03-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −86 | $584.80 | $50K | 49,687 |
| 2026-03-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −354 | $586.07 | $207K | 49,333 |
Page 136 of 171 · 3,408 trades